- Home
- ASA vs MGTX Comparison
ASA vs MGTX Comparison
Compare ASA & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASA
- MGTX
- Stock Information
- Founded
- ASA 1958
- MGTX 2015
- Country
- ASA United States
- MGTX United States
- Employees
- ASA N/A
- MGTX N/A
- Industry
- ASA Precious Metals
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASA Industrials
- MGTX Health Care
- Exchange
- ASA Nasdaq
- MGTX Nasdaq
- Market Cap
- ASA 585.6M
- MGTX 670.2M
- IPO Year
- ASA N/A
- MGTX N/A
- Fundamental
- Price
- ASA $35.16
- MGTX $8.09
- Analyst Decision
- ASA
- MGTX Strong Buy
- Analyst Count
- ASA 0
- MGTX 2
- Target Price
- ASA N/A
- MGTX $24.00
- AVG Volume (30 Days)
- ASA 119.3K
- MGTX 528.3K
- Earning Date
- ASA 09-02-2025
- MGTX 08-14-2025
- Dividend Yield
- ASA 0.17%
- MGTX N/A
- EPS Growth
- ASA 331.75
- MGTX N/A
- EPS
- ASA 14.01
- MGTX N/A
- Revenue
- ASA $3,923,667.00
- MGTX $37,917,000.00
- Revenue This Year
- ASA N/A
- MGTX $228.65
- Revenue Next Year
- ASA N/A
- MGTX $145.06
- P/E Ratio
- ASA $2.44
- MGTX N/A
- Revenue Growth
- ASA 66.52
- MGTX 366.84
- 52 Week Low
- ASA $18.51
- MGTX $3.85
- 52 Week High
- ASA $35.60
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- ASA 61.14
- MGTX 51.75
- Support Level
- ASA $33.90
- MGTX $7.43
- Resistance Level
- ASA $35.29
- MGTX $8.63
- Average True Range (ATR)
- ASA 0.89
- MGTX 0.43
- MACD
- ASA 0.06
- MGTX -0.05
- Stochastic Oscillator
- ASA 86.88
- MGTX 50.56
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.